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Summary In vivo nuclear magnetic resonance 31P spectroscopy was used to demonstrate different patterns of
high energy phosphate metabolism in a group of malignant tumours of glial origin. In some of the more
malignant tumours a decrease in adenylate energy charge was found. This was associated with a decline in
phosphocreatine and an increase in sugar phosphate and inorganic phosphorus.
"Human brain tumours have two metabolic features
which sharply distinguish them from brain. Brain
tumours have much lower metabolic rates than
brain and each particular tumour appears to have a
unique metabolic pattern" (Lowry et al., 1977). In
the past, determining the uniqueness of a brain
tumour's metabolic pattern was difficult and time
consuming. Recent developments in nuclear
magnetic resonance (NMR) spectroscopy (Gadian,
1977; Griffiths & Iles, 1980; Koeze, 1982) have
made it possible to assess rapidly several aspects of
high energy phosphate metabolism and pH of
tumours in vivo. This study was undertaken to
examine tumours for differences in high energy
phosphate metabolism using NMR spectroscopy
and to determine if these differences could be
related to such factors as tumour size, degree of
malignancy and histological features.
Materials and methods
Ten BD IX rats were injected with a suspension of
cells, designated A15A5, which originated from a
clone of neoplastic astrocytes derived from a mixed
glioma induced transplacentally by N-ethyl-N-
nitrosourea (Lantos et al., 1976). The cell lines were
maintained and all injections were performed in the
Department of Neuropathology of the Institute of
Psychiatry. Four animals were injected
intracerebrally with a cell suspension which had
undergone 23 passages. The injections were
performed 27 days before the in vivo NMR studies.
The remaining 6 rats were injected extracranially
beneath the scalp with cells at passage 34. The in
vivo NMR spectroscopy was performed 37 days
after the injection.
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The tumours varied greatly in size; the largest
weighed 16g and the smallest <1 g. The first 4
animals were anaesthetized with i.p. sodium
pentobarbitone, scanned and then sacrificed. The
tumour was bisected along the sagittal axis and
parasagittal blocks of tissue were embedded in
paraffin-wax. Sections were stained with
haematoxylin and eosin, Mallory's
phosphotungstic-acid haematoxylin (PTAH) for
astrocytic fibres, Lendrum's MSB method for
fibrin, gallocyanin-chrome alum and Feulgen's
reaction by the Neuropathology Laboratory of the
London Hospital Medical College. In addition an
attempt was made to demonstrate glial fibrillary
acidic protein using the PAP method. Of the
remaining 6 animals with extracerebral tumours
two were killed after the spectroscopy and the
tumour tissue was processed for histological
sections. Another two animals were allowed to
recover from the anaesthesia after the in vivo NMR
spectroscopy. One of these animals was killed 4
days after the spectroscopy and the tumour
extracted for in vitro spectroscopy as described
below. The other animal of this pair was killed 39
days after the in vivo NMR spectroscopy. The final
two animals had tumours too small to scan
properly. One of these was killed, the other was
allowed to survive for a further 66 days. It was
then killed and the tumour extracted for in vitro
spectroscopy as described below.
The in vivo 31P NMR spectroscopy was
performed at 32.5MHz with an Oxford Research
Systems TMR 32/200 (Gordon et al., 1982)
spectrometer. After the animal was anaesthetized, a
single turn surface coil (Ackerman et al., 1980)
-10mm in diameter was placed directly over the
tumour. In some animals records were obtained
with and without removal of the skin over the
tumour. The presence or absence of the skin could
not be detected by inspection of the spectroscopy
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records. The animal was placed inside the 200 mm
bore superconducting magnet for the recordings.
Typically between 600-800 scans were averaged.
The pulse angle was usually lOuS but ranged from
5 to 20uS. The time interval between scans was
usually 1 sec but recordings were often made at an
interval of 2 sec.
In vitro NMR spectroscopy was performed upon
extracted material. After the animal had been
anaesthetized with sodium pentobarbitone the
tumour was very quickly removed, clamped with
aluminium tongs precooled in liquid nitrogen and
ground into a fine powder while submerged in
liquid nitrogen. The frozen powder was treated with
3 vols of ice cooled 10% trichloroacetic acid in
20% methanol and centrifuged. The supernatant
was neutralized with tris buffer. This extract was
examined at 4° C in a Bruker WM 200 spectrometer
at 80.4MHz at the MRC Biomedical NMR Centre,
NIMR, Mill Hill.
Results
Figure 1 illustrates an in vivo NMR scan of tumour
number 1. Peak one contains the signals from
AMP, IMP and sugar phosphates (SP) (Gadian,
1982); peak 2, inorganic Phosphate (Pi). Peak 3 is
usually broad, sometimes absent and probably
represents the contribution of several
phosphodiesters (PDE), (Navon et al., 1977).
Peak 4 is also sometimes absent and contains the
signal from phosphocreatine (PCr) (Navon et al.,
1977). Peak 5 represents the signal from the
phosphate in ADP and ATP, peak 6 from ADP,
ATP and NAD. ATP alone is responsible for peak
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Figure 1 In vivo 31P NMR spectrum from tumour 1.
1200 scans averaged. Pulse width 10 is. Pulse delay 1 s.
PPM is parts per million of chemical shift referred to
phosphocreatine (peak 4). See text for details of peak
identification. The spectrum was obtained using
standard processing methods (Gadian, 1982; Gordon,
1982).
the peaks and the ratios of various phosphate
containing compounds to ATP can be calculated.
Table I lists the results from investigations of 9
rats. As noted by Griffiths et al. (1981) all tumours
showed the presence of Pi, SP and PDE. The ratios
of [Pi]/[ATP] and [SP]/[ATP] calculated from the in
vivo NMR scans appear to be closely correlated
(r=0.99). The correlation between [Pi]/[ATP] and
[PDE]/[ATP] ratios is rather less (r=0.67). This is
not surprising given the variation of [PDE] which
seems to occur in the same tumour over short
periods of time (Griffiths et al., 1981). Tumour 7
illustrates this variation. The NMR scan showed a
ratio of [PDE]/[ATP] of 1.42. Four days later the
animal was killed and the tumour extracteW. The
scan of the extracted material did not detect the
presence of PDE.
Another variable ratio was [PCr]/[ATP]. PCr was
present in substantial quantities in the first four
tumours with a passage number of 23. Eleven
passages later, PCr could not be detected in 3/5
tumours. The absence of PCr is associated with a
relatively high ratio of [Pi]/[ATP] and [SP]/[ATP]
but high ratios of these compounds did not
preclude the presence of PCr (see tumour 6). An
attempt was made to stimulate PCr production by
infusing 1 ml of 50% glucose i.p. into the animal
with tumour number 5. This would be expected to
raise the blood glucose by 500% after 30min
(Koeze, unpublished observations). The i.p.
injection, however, did not stimulate PCr synthesis.
nor did it appear to alter the [SP]/[ATP] ratios.
Similar results have been reported for Walker
sarcomas (Racker, 1976). The results of the in vitro
high resolution spectroscopy showed the absence of
PCr was not due to failure to detect the PCr peak
because of poor signal to noise ratio.
In these experiments it was not possible to
calculate the adenylate energy charge (Atkinson,
1977) because the molar concentrations of ATP,
ADP and AMP were not available. However, the
adenylate energy charge can be estimated from the
ratio of [ADP]/[ATP] if the adenylate kinase system
is assumed to be in equilibrium. The adenylate
energy charge for the tumours was determined
graphically by finding the intersection of the
[ADP]/[ATP] constant ratio line and the adenylate
kinase curve on a triangular composition graph
(Atkinson, 1977). The adenylate kinase curve was
calculated on the assumption of an equilibrium
constant of 1.2. The [ADP]/[ATP] ratio is easily
calculated in our own study by subtracting the area
of peak 7 from the area of peak 5 and dividing the
result by the area of peak 7. The scans of tumour 4
and 8 showed so little difference between peak 5
and 7 that the ratio was at or near zero. This was
interpreted as suggesting that very little ADP is
present. When the amount of ADP was so smallNMR SPECTROSCOPY OF TRANSPLANTED BRAIN TUMOUR
Table I Results of NMR Spectroscopy of implanted brain tumours
[Pul [SP] [PDEi [PCr] [ADP] Adenylate
Twmour energy
No. [ATP] [ATP] [ATP] [ATP] [ATP] charge pH Remarks
1 0.99 0.70 0.86 1.59 0.19 0.9 7.0 moderate necrosis, considerable
haemorrhage
2 1.04 0.80 1.39 1.88 0.24 0.9 7.2 one ofthe less necrotic tumours
3 0.97 0.63 0.79 1.04 0.17 0.9 6.9 one of the most necrotic tumours
4 0.66 0.35d 0.53d 0.94 oC 0.9 7.7 one of the less necrotic tumours
5 10.22 7.27 1.85 0 0.57 0.7 7.1 the largest tumour in the series moderate
necrosis
6 1.51 1.74 1.43 1.23 0.09 0.9 7.3 perhaps the least necrotic tumour
7 1.27 1.71 1.42d 0 0.23 0.8 7.1 In vivo NMR scan
2.20 2.75 0 0 0.36 7.1 In vitro NMR scan, no histology
8 0.71 0.84 1.19 1.68 Oe 0.9 7.1 moderate necrosisf
9 6.31 3.48 0.44 0.07 0.49 0.7 In vitro scan, no histology
aTumours 1-4 were transfer number 23 and had both intracranial and extracranial tumours. The 31P NMR studies were
performed 27 days after implantation.
bTumours 5-8 were transfer number 34 and the tumour was entirely extracranial. The 31P NMR studies were performed
34 days after implantation.
cTumour 9 was transfer number 34, extracranial and the 31P NMR study was performed 66 days after implantation.
dThe measurement of the area was difficult either because of low S/N ratio or difficulty in determining a baseline.
eThe value of the area of peak 5 minus the value of the area of peak 7 was so small that the ratio could not be
calculated.
fHistological material obtained 39 days after the scan.
that the ratio of [ADP]/[ATP] was at or near zero
because of the small amount of ADP detected, the
adenylate energy charge was arbitrarily given as
>0.9.
Because Pi is present as an equilibrium between
the H2PO and the HPO4- ions at physiological
pH (pk=6.8), the chemical shift of the Pi
resonance defines the intracellular pH. The latter
may be determined by comparison with previously
constructed titration curves of Pi chemical shift
versus pH. The absolute accuracy of this method is
probably about 0.1 pH unit although changes in pH
may be measured with an accuracy of 0.05pH units
(Gadian, 1982). It has been suggested by Griffiths
et al. (1981) that the intracellular pH of tumours
might be abnormally acidic because of the known
dependence of tumours on aerobic glycolysis
(Racker, 1976). They did not, however, find much
evidence for a pH that differed from the pH of
surrounding muscle in the Walker carcinosarcoma
or fibrosarcoma xenographs. The tumours, as
shown in Table I, showed intracellular pH values,
based upon the chemical shift of Pi which ranged
between 6.9 and 7.7. Although it is extremely
difficult to assess the relative degree of necrosis,
especially when the assessment is based upon 2 or 3
sections through the centre of the tumour, it did
appear that the more necrotic tumours had a lower
pH than the less necrotic tumours.
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Figure 2 Effect upon chemical shift of Pi (PPM) with
increasing pulse angle (us). In vivo 31P NMR scan
tumour 5. Average of 600 scans. One sec pulse delay.
The large peak at a chemical shift -5.00PPM is the
Pi signal.
was increased. This has the effect of altering the
depth of the sampling area from a more superficial
to a deeper location (Gadian, 1982). An example of
the scans obtained at different- pulse widths is
shown in Figure 2 and the results are given in
Table II. As the RF probe went "deeper" into the
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Table II pH at increasing pulse angle in three tumours
Pulse Chem. shift Chem. shift Chem. shift
width Pi Pi Pi
its 7iTmour 2 pH Thmour 5 pH Tumour 6 pH
5 4.99 7.1 5.17 7.3 4.99 7.1
10 5.05 7.2 4.93 7.1 5.17 7.3
15 5.29 7.4 5.17 7.3 5.05 7.2
20 5.29 7.4 5.23 7.4 5.05 7.2
25 5.41 7.6
tissue, the pH became more alkaline in tumour 2
but the results.were equivocal in the other tumours.
The tumour cell line, A15AS, used in this study has
been characterized both in vitro and in vivo with
both optical and electron microscopy (Claisse et al.,
1979; Davaki & Lantos, 1980, 1981). The cells of
this line give rise to malignant astrocytomas when
injected s.c. or intracerebrally into appropriate
hosts (Lantos et al., 1976; Davaki & Lantos, 1981).
The histology of the tumours depended to some
extent on the passage number. The 4 tumours
transplanted after 23 passages consisted mainly of
two cell types. The first was a pleomorphic cell,
polygonal, stellate or bipolar with oval or round
hyperchromatic nuclei and abundant eosinophilic
cytoplasm. These cells were frequently seen around
blood vessels and also found in the tumours which
had been injected after 34 passages. The second
type of cell present mainly in the periphery, was
spindle shaped and formed a loosely woven tissue
in which the cells were haphazardly distributed in
the fibrillary matrix.
A third type of cell was unique to the tumours
injected after 34 passages. This cell was bipolar
with elongated nuclei which contained a finely
stippled chromatin. The Feulgen's reaction was less
evident in these cells and they also showed
somewhat less affinity for gallocyanin. These cells
formed tightly packed parallel or interlacing
bundles and appeared to be mitotically active.
The trichrome stain revealed collagen in all the
tumours. This was more evident at the periphery of
the tumour and was most prominent in areas
composed of spindle shaped cells. All the tumours
showed evidence of necrosis, the severity of which
was related to the size of the neoplasm. The extent
of necrosis, however, varied within the same
tumour: small serpiginous and massive confluent
necrosis was seen, and the latter frequently became
cystic.
The vascularity of the tumours was variable, but
even in the best vascularized areas the pronounced
endothelial hyperplasia, associated with malignant
gliomas, did not occur. Binucleate cells were
occasionally seen but multinucleate giant cells were
absent. Staining of astrocytic fibres with PTAH
gave equivocal results. The reaction to glial
fibrillary astrocytic protein (GFAP) was entirely
negative.
On the whole the first four neoplasms (passage
number 23) were smaller, better vascularized and
had undergone less devastating necrosis than the
second group of neoplasms (passage number 34).
These features and the greater mitotic activity of
the cells in the second group all suggest that
tumours produced by cells of higher passage
number are more malignant.
The first 4 animals had both intracranial and
extracranial tumours. The latter were the result of
the tumour growing back along the injection site
through the small cranial burr hole. The
intracranial neoplasms showed far less variety in
cell type and cellular arrangements, the cells
resembling the first type described above. The
nuclei of all the tumour cells showed a much more
marked Feulgen's reaction and affinity for
gallocyanin than the surrounding cells of the
cerebral tissue.
Discussion
Atkinson (1977) believed that for most cells under
nearly all conditions of steady state metabolism, the
adenylate energy charge has a value between 0.87
and 0.94. Lowry et al. (1977) directly measured the
high energy phosphate content of biopsy material
from human gliomas and found values of adenylate
charge between 0.57 to 0.91. In our study there are
so many assumptions underlying the conversion of
the [ADP]/[ATP] ratio to adenylate energy charge
that the values found are likely to be only rough
approximations. For example, one of the
assumptions is that the pH environment within and
between tumours is constant and this is clearly not
the case as illustrated in Tables I and II. [Mg]++
will also affect the value of the energy charge and
the value of this variable is completely unknown in
our study (Gupta & Yushok, 1980; Hoult et al.,
1974). Furthermore the meaning and role of theNMR SPECTROSCOPY OF TRANSPLANTED BRAIN TUMOUR 361
adenylate energy charge concept for both in vitro
and in vivo systems has been criticized by Purich &
Fromm (1973). It should also be pointed out that
in several tissues the concentrations of ADP and Pi
measured by in vivo 31P NMR are consistently
lower than measurements made by more
conventional methods (Ackerman et al., 1980; Iles
et al., 1982). Nevertheless the 3 tumours which
showed zero or near zero ratios of [PCr]/[ATP]
because of an absent PCr peak on the NMR scan
were the 3 tumours with the lowest adenylate
energy charge. These three values are outside the
range given by Atkinson (1977). Associated with
this low [PCr]/[ATP] ratio and adenylate energy
charge was an increased [SP]/[ATP] and [Pi]/[ATP]
ratio both as a result of great increases in [SP] and
[Pi]. Further evidence to suggest that the low
adenylate energy charge was not the result of a lack
of glucose substrate comes from the failure of an
i.p. glucose infusion to stimulate the production of
PCr.
All 3 tumours with the low energy charge
belonged to the group of tumours produced by cells
at 34 passages. These tumours were less
differentiated than the tumours with 23 passages. A
third type of cell with diminished RNA and DNA
was evident in all of these more malignant tumours,
including the 2 tumours with "normal" adenylate
energy charge. There were no other factors such as
pH, degree of necrosis or tumour size that could be
exclusively associated with the fall in adenylate
energy charge.
The tumours used in these experiments had
greatly differing growth rates and presumably
different metabolic patterns. The change in the high
energy phosphate metabolism noted in the second,
more malignant group of tumours may be related
to the appearance of a new cell type. Only serial
studies will reveal if the reduced adenylate charge
associated with diminished PCr occurs in the early
stages of growth or ifit is a feature of late growth.
We wish to acknowledge the assistance of Mr. B. Deane
who transplanted the tumours, Mr. P. Martin who
performed much of the NMR spectroscopy, Dr. C.
Scholtz who arranged for the histological stains and the
MRC Biomedical NMR Centre, NIMR, Mill Hill for
making NMR facilities available.
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